Table 2.
Risk factors and types of devices in patients with LVAD using an ARNI.
| Study | Risk Factors | Type of LVAD | ||||
|---|---|---|---|---|---|---|
| Hypertension | Diabetes | Chronic Kidney Disease | HVAD | HM2 | HM3 | |
| Alishetti et al., 2020 [13] | 24 (80%) | 12 (40%) | - | 1 (3.3%) | 12 (40%) | 17 (57%) |
| Sharma et al., 2020 [16] | 5 (100%) | 3 (60%) | - | 4 (80%) | 1 (20%) | - |
| Zorz et al., 2020 [17] | - | - | - | - | - | - |
| Randhawa et al., 2020 [9] | - | - | - | - | - | - |
| Schnettler et al., 2021 [15] | - | - | - | - | - | - |
| Goldberg et al., 2021 [8] | - | - | - | - | - | - |
| Rawley et al., 2023 [14] | 73 (88%) | - | 42 (50.6%) | - | - | - |
Data are presented as numbers (percentages). Abbreviations: HM2, Heartmate 2; HM3, Heartmate 3; HVAD, Heartware Ventricular Assist Device; LVAD, left ventricular assist device.